Phase II study of R-CEOP 1-8 for aggressive non-Hodgkin lymphoma in elderly patients

被引：0
|
作者：
Marelli, M.
Bascialla, L.
Chini, C.
Proserpio, I
Gueli, R.
Pinotti, G.
机构：
[1] Azienda Osped Osped Circolo, UO Oncol Med, Varese, Italy
[2] Fdn Macchi, Varese, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI57 / XI57
页数：1
相关论文
共 50 条
  • [1] R-CEOP 1-8 regimen for treatment of elderly patients with diffuse large B-cell lymphoma
    Bascialla, Linda
    Marelli, Maria
    Chini, Claudio
    Proserpio, Ilaria
    Gueli, Rossana
    Pinotti, Graziella
    ANNALS OF ONCOLOGY, 2006, 17 : 200 - 201
  • [2] CEOP 1-8 regimen for treatment of intermediate-high grade non-Hodgkin's lymphoma in elderly patients
    Chini, C
    Campiotti, L
    Pigni, A
    Fagnoni, E
    Proserpio, I
    Martinelli, B
    Pinotti, G
    ANNALS OF ONCOLOGY, 2000, 11 : 51 - 51
  • [3] Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma -: a phase II study
    Späth-Schwalbe, E
    Lange, C
    Genvresse, I
    Krüuger, L
    Eucker, J
    Schweigert, M
    Sezer, O
    Budach, V
    Possinger, K
    ANTI-CANCER DRUGS, 2002, 13 (04) : 395 - 403
  • [4] Phase II study of cyclophosphamide, prednisone, and etoposide (CEOP-E) lymphoma epirubicin, vincristine, for aggressive non-Hodgkin's
    Kim, JG
    Sohn, SK
    Kim, DH
    Baek, JH
    Park, TI
    Lee, KB
    JOURNAL OF KOREAN MEDICAL SCIENCE, 2004, 19 (06) : 820 - 825
  • [5] Treatment of elderly patients with aggressive non-Hodgkin's lymphoma
    Fridrik, MA
    ONKOLOGIE, 1998, 21 (03): : 251 - 254
  • [6] European experiences on aggressive non-Hodgkin's lymphoma in elderly patients
    Fratino, L
    Bernardi, D
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2004, 51 (03) : 229 - 240
  • [7] Treatment of elderly patients with aggressive non-Hodgkin's lymphoma.
    Paccalin, M
    Lacotte-Thierry, L
    Delwail, V
    REVUE DE MEDECINE INTERNE, 2002, 23 (07): : 632 - 637
  • [8] A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma
    Mitchell, Paul L. R.
    Marlton, Paula
    Grigg, Andrew
    Seymour, John F.
    Hertzberg, Mark
    Enno, Arno
    Herrmann, Richard
    Bond, Rodney
    Arthur, Chris
    LEUKEMIA & LYMPHOMA, 2008, 49 (05) : 924 - 931
  • [9] CEOP treatment results and validity of the international prognostic index in Chinese patients with aggressive non-Hodgkin's lymphoma
    Chim, CS
    Kwong, YL
    Lie, AKW
    Lee, CK
    Liang, R
    HEMATOLOGICAL ONCOLOGY, 1998, 16 (03) : 117 - 123
  • [10] Phase II study of topotecan plus etoposide in patients with aggressive histology non-Hodgkin's lymphoma (NHL).
    Crump, M
    Meyer, R
    Couban, S
    Rudinskas, L
    Hoskins, P
    Zanke, B
    Gluck, S
    Maksymiuk, A
    Matthews, S
    Eisenhauer, E
    BLOOD, 1999, 94 (10) : 526A - 526A
12345